Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study - Sureda, A.; García-Sanz, R.; Domingo-Domenech, E.; Capote, F.J.; Gutiérrez, A.; Rodriguez, A.; Aguiar, D.; Giraldo, P.; Infante, M.S.; López-Jiménez, J.; Martínez, C.; Sánchez-González, B.; et al. (Cancers, 2025)